Clelia Di Serio
- Molecular Biology top 5%
- Genetics top 1%
- Oncology top 2%
- Immunology top 2%
- Epidemiology top 5%
- Co-authors
- Luigi NaldiniAlessandro AmbrosiAlessandro NonisEugenio MontiniFrancesca SanvitoManfred SchmidtCynthia C. BartholomaeChristof von Kalle
- Topics
- Virus-based gene therapy research (13 papers)CRISPR and Genetic Engineering (8 papers)HIV Research and Treatment (7 papers)
- Cited by
- GeneticsImmunologyOncology
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Medicine
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Clelia Di Serio
83 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Molecular Biology 2.3k
- Genetics 1.5k
- Oncology 1.1k
- Immunology 1.0k
- Epidemiology 606
Countries citing papers authored by Clelia Di Serio
This map shows the geographic impact of Clelia Di Serio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clelia Di Serio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clelia Di Serio more than expected).
Fields of papers citing papers by Clelia Di Serio
This network shows the impact of papers produced by Clelia Di Serio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clelia Di Serio. The network helps show where Clelia Di Serio may publish in the future.
Co-authorship network of co-authors of Clelia Di Serio
This figure shows the co-authorship network connecting the top 25 collaborators of Clelia Di Serio. A scholar is included among the top collaborators of Clelia Di Serio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clelia Di Serio. Clelia Di Serio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 5 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 20 | |
| 8 | 14 | |
| 9 | 19 | |
| 10 | 3 | |
| 11 | 12 | |
| 12 | 106 | |
| 13 | 104 | |
| 14 | 10 | |
| 15 | 103 | |
| 16 | 10 | |
| 17 | 60 | |
| 18 | 186 | |
| 19 | 204 | |
| 20 | 42 |
About Clelia Di Serio
Clelia Di Serio is a scholar working on Virology, Modeling and Simulation and General Decision Sciences, having authored 87 papers that have together received 4.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (13 papers), CRISPR and Genetic Engineering (8 papers) and HIV Research and Treatment (7 papers). The work is most often cited by research in Genetics (1.5k citations), Immunology (1.0k citations) and Oncology (1.1k citations). Clelia Di Serio has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Luigi Naldini, Alessandro Ambrosi, Alessandro Nonis, Eugenio Montini, Francesca Sanvito, Manfred Schmidt, Cynthia C. Bartholomae, Christof von Kalle, Claudio Doglioni and Maurilio Ponzoni. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.